Other studies have also demonstrated the pro-invasive nature of GSK3β in colorectal, pancreatic and breast cancer cells via the modulation of cytoskeletal microstructures and cytokine-mediated extracellular matrix degradation [44,64,69]. This evidence concerns the gene GSK3B and breast carcinoma.